1. Home
  2. HTCO vs KRRO Comparison

HTCO vs KRRO Comparison

Compare HTCO & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTCO
  • KRRO
  • Stock Information
  • Founded
  • HTCO 2022
  • KRRO 2014
  • Country
  • HTCO Singapore
  • KRRO United States
  • Employees
  • HTCO N/A
  • KRRO N/A
  • Industry
  • HTCO
  • KRRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTCO
  • KRRO Health Care
  • Exchange
  • HTCO NYSE
  • KRRO Nasdaq
  • Market Cap
  • HTCO N/A
  • KRRO 209.6M
  • IPO Year
  • HTCO N/A
  • KRRO 2019
  • Fundamental
  • Price
  • HTCO $1.11
  • KRRO $17.44
  • Analyst Decision
  • HTCO
  • KRRO Strong Buy
  • Analyst Count
  • HTCO 0
  • KRRO 7
  • Target Price
  • HTCO N/A
  • KRRO $132.17
  • AVG Volume (30 Days)
  • HTCO 257.4K
  • KRRO 90.5K
  • Earning Date
  • HTCO 01-01-0001
  • KRRO 03-18-2025
  • Dividend Yield
  • HTCO N/A
  • KRRO N/A
  • EPS Growth
  • HTCO N/A
  • KRRO N/A
  • EPS
  • HTCO N/A
  • KRRO N/A
  • Revenue
  • HTCO $108,176,683.00
  • KRRO $2,271,000.00
  • Revenue This Year
  • HTCO N/A
  • KRRO N/A
  • Revenue Next Year
  • HTCO N/A
  • KRRO N/A
  • P/E Ratio
  • HTCO N/A
  • KRRO N/A
  • Revenue Growth
  • HTCO 13.56
  • KRRO N/A
  • 52 Week Low
  • HTCO $0.21
  • KRRO $16.78
  • 52 Week High
  • HTCO $4.50
  • KRRO $98.00
  • Technical
  • Relative Strength Index (RSI)
  • HTCO N/A
  • KRRO 30.50
  • Support Level
  • HTCO N/A
  • KRRO $16.78
  • Resistance Level
  • HTCO N/A
  • KRRO $25.25
  • Average True Range (ATR)
  • HTCO 0.00
  • KRRO 2.90
  • MACD
  • HTCO 0.00
  • KRRO -0.20
  • Stochastic Oscillator
  • HTCO 0.00
  • KRRO 5.67

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Share on Social Networks: